{"pmid":32464641,"title":"Does epicardial fat contribute to COVID-19 myocardial inflammation?","text":["Does epicardial fat contribute to COVID-19 myocardial inflammation?","Eur Heart J","Malavazos, Alexis Elias","Goldberger, Jeffrey J","Iacobellis, Gianluca","32464641"],"journal":"Eur Heart J","authors":["Malavazos, Alexis Elias","Goldberger, Jeffrey J","Iacobellis, Gianluca"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32464641","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1093/eurheartj/ehaa471","topics":["Mechanism"],"weight":1,"_version_":1668079521348190208,"score":9.490897,"similar":[{"pmid":32365275,"title":"Obesity accompanying COVID-19: the role of epicardial fat.","text":["Obesity accompanying COVID-19: the role of epicardial fat.","With interest we read the study by Simonnet A et al. (1) in which important novel evidence is addressed that obesity is highly frequent among critically ill patients with severe acute respiratory syndrome coronavirus-2 (SARS-Cov-2) infection. Although clinically very relevant, it remains difficult to elucidate the mechanisms by which SARS-Cov-2 severity is increased in the context of obesity. As reported by Katz JN et al. (2), 28% of hospitalised patients with coronavirus disease 2019 (COVID-19) presented cardiac complications including myocarditis, arrhythmias, heart failure (HF) and sudden death. Considering that myocardial response in COVID-19 is closely associated with in-hospital mortality, local biological effects on myocardial tissue from epicardial adipose tissue (EAT) is warrant further discussion.","Obesity (Silver Spring)","Zhao, Lei","32365275"],"abstract":["With interest we read the study by Simonnet A et al. (1) in which important novel evidence is addressed that obesity is highly frequent among critically ill patients with severe acute respiratory syndrome coronavirus-2 (SARS-Cov-2) infection. Although clinically very relevant, it remains difficult to elucidate the mechanisms by which SARS-Cov-2 severity is increased in the context of obesity. As reported by Katz JN et al. (2), 28% of hospitalised patients with coronavirus disease 2019 (COVID-19) presented cardiac complications including myocarditis, arrhythmias, heart failure (HF) and sudden death. Considering that myocardial response in COVID-19 is closely associated with in-hospital mortality, local biological effects on myocardial tissue from epicardial adipose tissue (EAT) is warrant further discussion."],"journal":"Obesity (Silver Spring)","authors":["Zhao, Lei"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32365275","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1002/oby.22867","topics":["Treatment"],"weight":1,"_version_":1666138495975948290,"score":55.545868}]}